loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Deuterium Oxide

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Deuterium Oxide

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,260Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Poxel Initiates Phase 2 NASH Trial for PXL065 in Biopsy-Proven Patients
    Poxel Initiates Phase 2 NASH Trial for PXL065 in Biopsy-Proven Patients

    02 Sep 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200901005908/en/Poxel-Initiates-Phase-2-NASH-Trial-PXL065

    BUSINESSWIRE
    02 Sep 2020
    Share Share
    Deuterium Depletion is a Disruptive Innovation in Pharma Industry - HYD Pharma
    Deuterium Depletion is a Disruptive Innovation in Pharma Industry - HYD Pharma

    13 Mar 2019

    // BIOSPACE

    https://www.biospace.com/article/deuterium-depletion-is-a-disruptive-innovation-in-the-pharma-industry-hyd-pharma-develops-new-deuterium-depleted-drugs-for-the-treatment-of-neoplastic-and-metabolic-diseases/

    BIOSPACE
    13 Mar 2019
    Share Share